Maytansinoid DM4 is a cytotoxic agent that inhibits microtubule assembly by binding to tubulin at the rhizoxin binding site. It is a derivative of maytansine and is used as an active pharmaceutical ingredient in research and manufacturing contexts.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Maytansinoid DM4?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ravtansine
pharmaceutical raw material
Sulfachlorpyridazine
pharmaceutical raw material
Sulfamethoxypyridazine
pharmaceutical raw material
Homatropine methylbromide
pharmaceutical raw material
Anisotropine methylbromide
pharmaceutical raw material
ANSAMITOCIN DERIV
pharmaceutical intermediate
[(1S,3S,5S,6S,16Z,18Z,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,2,5,9,16-pentamethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] (2S)-2-[methyl-(4-methyl-4-sulfanylpentanoyl)amino]propanoate
SVVGCFZPFZGWRG-CFYIETIYSA-N
C/C/1=C/C=C\[C@H]([C@]2(C[C@@H](C([C@H]3[C@@](O3)([C@H](CC(=O)N(C4=C(C(=CC(=C4)C1)OC)Cl)C)OC(=O)[C@H](C)N(C)C(=O)CCC(C)(C)S)C)(C)C)OC(=O)N2)O)OC
Sourcing Maytansinoid DM4?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.